Adaptimmune Therapeutics
ADAP
#9324
Rank
ยฃ51.48 M
Marketcap
ยฃ0.20
Share price
-20.31%
Change (1 day)
-81.54%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: ยฃ51.48 Million

As of April 2025 Adaptimmune Therapeutics has a market cap of ยฃ51.48 Million. This makes Adaptimmune Therapeutics the world's 9324th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ51.48 M-57.2%
2024ยฃ0.12 B-14.9%
2023ยฃ0.14 B-28.5%
2022ยฃ0.19 B-54.44%
2021ยฃ0.43 B-29.1%
2020ยฃ0.61 B536.01%
2019ยฃ96.24 M-79.68%
2018ยฃ0.47 B2.3%
2017ยฃ0.46 B99.31%
2016ยฃ0.23 B-59.67%
2015ยฃ0.57 B

End of Day market cap according to different sources

On Apr 5th, 2025 the market cap of Adaptimmune Therapeutics was reported to be:

ยฃ0.30 Billion
by Nasdaq info icon info icon
ยฃ51.48 Million
by CompaniesMarketCap info icon info icon
ยฃ51.48 Million
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ0.77 B 1,411.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.78 M-77.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.37 B 629.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ7.50 B 14,473.36%๐Ÿ‡บ๐Ÿ‡ธ USA